| 000 | 01822 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250518014329.0 | ||
| 264 | 0 | _c20190528 | |
| 008 | 201905s 0 0 eng d | ||
| 022 | _a1177-8881 | ||
| 024 | 7 |
_a10.2147/DDDT.S175763 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDai, Qiaoding | |
| 245 | 0 | 0 |
_aCurcumin alleviates rheumatoid arthritis-induced inflammation and synovial hyperplasia by targeting mTOR pathway in rats. _h[electronic resource] |
| 260 |
_bDrug design, development and therapy _c2018 |
||
| 300 |
_a4095-4105 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xpharmacology |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xpharmacology |
| 650 | 0 | 4 |
_aArthritis, Experimental _xchemically induced |
| 650 | 0 | 4 | _aCollagen Type II |
| 650 | 0 | 4 |
_aCurcumin _xpharmacology |
| 650 | 0 | 4 | _aHyperplasia |
| 650 | 0 | 4 |
_aInflammation Mediators _xmetabolism |
| 650 | 0 | 4 |
_aInterleukin-1beta _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMatrix Metalloproteinase 1 _xmetabolism |
| 650 | 0 | 4 |
_aMatrix Metalloproteinase 3 _xmetabolism |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xmetabolism |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aSirolimus _xpharmacology |
| 650 | 0 | 4 |
_aSynovial Membrane _xdrug effects |
| 650 | 0 | 4 |
_aSynovitis _xchemically induced |
| 650 | 0 | 4 |
_aTOR Serine-Threonine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xmetabolism |
| 700 | 1 | _aZhou, Di | |
| 700 | 1 | _aXu, Liping | |
| 700 | 1 | _aSong, Xinwei | |
| 773 | 0 |
_tDrug design, development and therapy _gvol. 12 _gp. 4095-4105 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2147/DDDT.S175763 _zAvailable from publisher's website |
| 999 |
_c29196639 _d29196639 |
||